Ara h 1 CD4+ T cell epitope-based peptides: candidates for a peanut allergy therapeutic
Version of Record online: 28 MAY 2013
© 2013 John Wiley & Sons Ltd
Clinical & Experimental Allergy
Volume 43, Issue 6, pages 684–697, June 2013
How to Cite
Clinical & Experimental Allergy 2013; 43 684–697., , , , , , .
- Issue online: 28 MAY 2013
- Version of Record online: 28 MAY 2013
- Accepted manuscript online: 2 APR 2013 04:31AM EST
- Manuscript Accepted: 27 FEB 2013
- Manuscript Revised: 25 FEB 2013
- Manuscript Received: 11 OCT 2012
- Ilhan Food Allergy Foundation
- National Health and Medical Research Council of Australia
|cea12113-sup-0001-FigureS1.tif||image/tif||1811K||Figure S1. Representative CFSE-based assay for detecting CD4+ T cell proliferation in PBMC.|
|cea12113-sup-0002-FigureS2.tif||image/tif||2005K||Figure S2. Representative HLA class II restriction specificity of T cell epitope recognition.|
Table S1. Subject demographics.
Table S2. HLA genotyping for subjects used for T cell line generation.
Table S3. Ara h 1 20-mer peptides.
Table S4. Predicted HLA-DR binding motifs in selected Ara h 1 20-mers.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.